Intellectual Property India Publishes Patent Application for 'A Method For Selecting Ovarian Cancer Patients For Parp Inhibitor Treatment' Filed by Onecell Diagnostics India Private Limited; and Onecell Diagnostics, Inc.

MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202421010878 A) filed by Onecell Diagnostics India Private Limited; and Onecell Diagnostics, Inc., Pune, Maharashtra, on Feb. 16, 2024, for 'a method for selecting ovarian cancer patients for parp inhibitor treatment.'

Inventor(s) include Mohan Uttarwar; Gowhar Shafi; P M Shivamurthy; Anand Raj Ulle; Chongtham Cha Chinglemba; and Jayant Jagannath Khandare.

The application for the patent was published on Aug. 22, under issue no. 34/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to a method for selection of ovarian cancer patients for treatment with PARP inhibitors. This involves 1) prepari...